1. Bourut C, Chenu E, Godenèche D, Madelmont JC, et al. Cytostatic action of two nitrosoureas derived from cysteamine. British Journal of Cancer 89: 539–546, 1986
2. Filippeschi S, Colombo T, Bassani D, de Francesco L, et al. Antitumor activity of the novel nitrosourea S 10036 in rodent tumors. Anticancer Research 8: 1351–1354, 1988
3. Godenèche D, Labarre P, Moreau MF, Madelmont JC, et al. Main urinary metabolites of two cysteamine containing 2-(chloroethyl) nitrosoureas in rats. Drug Metabolism and Disposition 21: 91–99, 1993
4. Godenèche D, Madelmont JC, Labarre P, Plagne R, Meyniel G. Disposition of new sulphur-containing 2-(chloroethyl) nitrosoureas in rats. Xenobiotica 17: 59–70, 1987
5. Gunnarsson PO, Vibe-Petersen J, Macpherson JS, Warrington PS, et al. Pharmacokinetics of tauromustine in cancer patients. Cancer Chemotherapy and Pharmacology 23: 176–180, 1989